Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; the references it cites are not checked yet.

Outcomes in children of women with type 2 diabetes exposed to metformin versus placebo during pregnancy (MiTy Kids): a 24-month follow-up of the MiTy randomised controlled trial

Open access
Feig, Denice S, Sanchez, J Johanna, Murphy, Kellie E, Asztalos, Elizabeth, Zinman, Bernard, Simmons, David, Haqq, Andrea M, Fantus, I George, Lipscombe, Lorraine, Armson, Anthony, Barrett, Jon, Donovan, Lois, Karanicolas, Paul, Tobin, Siobhan, Mangoff, Kathryn, Klein, Gail, Jiang, Yidi, Tomlinson, George, Hamilton, Jill, Feig, DS, Galper, A, Cleave, B, Strom, M, Poolman, K, Fong, D, Viguiliouk, E, Legault, L, Boutin, L, Ho, J, Virtanen, H, Zahedi, A, Szwiega, K, Coolen, J, Dias, R, Sellers, E, Fletcher, B, Bourrier, L, Haqq, A, Rylance, H, Hadjiyannakis, S, Courtney, J, McManus, R, Halperin, I, Miller, D, Coles, K, Simmons, D, Nema, J, Weisnagel, SJ, Dubé, MC, Chanoine, JP, Kwan, J, McIntyre, HD, Laurie, J, Maguire, F, Soper, J, Bridger, T, Houlden, R, Breen, A, McLean, M, Duke, A, Hendon, S, Sigmund, A · 2023 · The Lancet Diabetes & Endocrinology

Abstract

Background Metformin is increasingly being used during pregnancy, with potentially adverse long-term effects on children. We aimed to examine adiposity in children of women with type 2 diabetes from the Metformin in Women with Type 2 Diabetes in Pregnancy (MiTy) trial, with and without in-utero exposure to metformin, up to 24 months of age.Methods MiTy Kids is a follow-up study that included infants of women who participated in the MiTy randomised controlled trial, receiving either oral 1000 mg metformin twice daily or placebo. Caregivers and researchers remained masked to the type of medication (metformin or placebo) mothers received during their pregnancy. Anthropometric measurements, including weight, height, and skinfold thicknesses, were taken at 3, 6, 12, 18, and 24 months. At 24 months, linear regression was used to compare the BMI Z score and sum of skinfolds in the metformin versus placebo groups, adjusted for confounders. Fractional polynomials were used to assess growth trajectories. This study is registered with ClinicalTrials.gov, NCT01832181.Findings Of the 465 eligible children, 283 (61%) were included from 19 centres in Canada and Australia. At 24 months, there was no difference between groups in mean BMI Z score (0·84 [SD 1·52] with metformin vs 0·91 [1·38] with placebo; mean difference 0·07 [95% CI -0·31 to 0·45], p=0·72) or mean sum of skinfolds (23·0 mm [5·2] vs 23·8 mm [5·4]; mean difference 0·8 mm [-0·7 to 2·3], p=0·31). Metformin was not a predictor of BMI Z score at 24 months of age (mean difference -0·01 [95% CI -0·42 to 0·37], p=0·92). There was no overall difference in BMI trajectory but, in males, trajectories were significantly different by treatment (p=0·048); BMI in the metformin group was higher between 6 and 24 months. Children of women with type 2 diabetes were approximately 1 SD heavier than the WHO reference population.Interpretation Anthropometrics were similar in children exposed and those not exposed to metformin in utero; hence, overall, data are reassuring with regard to the use of metformin during pregnancy in women with type 2 diabetes and the long-term health of their children.Funding Canadian Institute for Health Research.

Overview

Integrity signals

Registry

Crossref · 10.1016/s2213-8587(23)00004-9

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

The citation lists are queued

They are fetched later and appear here then.

References 32 · Cited by 61

Metadata

Authors
Feig, D. S., Sanchez, J. J., Murphy, K. E., Asztalos, E., Zinman, B., Simmons, D., Haqq, A. M., Fantus, I. G., Lipscombe, L., Armson, A., Barrett, J., Donovan, L., Karanicolas, P., Tobin, S., Mangoff, K., Klein, G., Jiang, Y., Tomlinson, G., Hamilton, J., Feig, D., Galper, A., Cleave, B., Strom, M., Poolman, K., Fong, D., Viguiliouk, E., Legault, L., Boutin, L., Ho, J., Virtanen, H., Zahedi, A., Szwiega, K., Coolen, J., Dias, R., Sellers, E., Fletcher, B., Bourrier, L., Haqq, A., Rylance, H., Hadjiyannakis, S., Courtney, J., McManus, R., Halperin, I., Miller, D., Coles, K., Simmons, D., Nema, J., Weisnagel, S., Dubé, M., Chanoine, J., Kwan, J., McIntyre, H., Laurie, J., Maguire, F., Soper, J., Bridger, T., Houlden, R., Breen, A., McLean, M., Duke, A., Hendon, S., & Sigmund, A.
Affiliations
  • Mount Sinai Hospital (CA)
  • Sunnybrook Hospital (CA)
  • Sunnybrook Health Science Centre (CA)
  • Western Sydney University (AU)
  • University of Alberta (CA)
  • University of Toronto (CA)
  • Dalhousie University (CA)
  • University of Calgary (CA)
  • University Health Network (CA)
Venue
The Lancet Diabetes & Endocrinology
Publisher
Elsevier BV
Published
2023-03
Volume
11
Issue
3
Pages
191-202
ISSN
2213-8587 (ISSN-L)
OpenAlex
W4319067708
Cited by
61
References
32
Citations by year
2026: 11 · 2025: 18 · 2024: 18 · 2023: 14
FWCI
19.03
Type
journal article
Language
en
Open access
Locations
  • The Lancet Diabetes & Endocrinology (publishedVersion)
  • PubMed (publishedVersion)
  • TSpace (University of Toronto) (submittedVersion, cc-by-nc-nd)
Funders
  • Canadian Institutes of Health Research
  • University of Guelph
Topics
  • Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Birth, Development, and Health
Keywords
metformin, type 2 diabetes in pregnancy, maternal type 2 diabetes, prenatal drug exposure, childhood adiposity, BMI z-score, skinfold thickness, growth trajectories, infant anthropometry, long-term outcomes, offspring of diabetic mothers, sex differences in growth, gestational weight gain
MeSH terms
Canada, Child, Diabetes Mellitus, Type 2, Female, Follow-Up Studies, Humans, Hypoglycemic Agents, Infant, Metformin, Pregnancy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Outcomes in children of women with type 2 diabetes exposed to metformin versus placebo during pregnancy (MiTy Kids): a 24-month follow-up of the MiTy randomised controlled trial. https://app.cochat.ai/papers/10.1016/s2213-8587(23)00004-9
The paper
Feig, D. S., Sanchez, J. J., Murphy, K. E., Asztalos, E., Zinman, B., Simmons, D., Haqq, A. M., Fantus, I. G., Lipscombe, L., Armson, A., Barrett, J., Donovan, L., Karanicolas, P., Tobin, S., Mangoff, K., Klein, G., Jiang, Y., Tomlinson, G., Hamilton, J., . . . Sigmund, A. (2023). Outcomes in children of women with type 2 diabetes exposed to metformin versus placebo during pregnancy (MiTy Kids): a 24-month follow-up of the MiTy randomised controlled trial. The Lancet Diabetes & Endocrinology. https://doi.org/10.1016/s2213-8587(23)00004-9

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.